UA80870C2 - Method for treatment or prevention of aspergillus infections with thymosin alpha 1 - Google Patents

Method for treatment or prevention of aspergillus infections with thymosin alpha 1

Info

Publication number
UA80870C2
UA80870C2 UAA200509921A UA2005009921A UA80870C2 UA 80870 C2 UA80870 C2 UA 80870C2 UA A200509921 A UAA200509921 A UA A200509921A UA 2005009921 A UA2005009921 A UA 2005009921A UA 80870 C2 UA80870 C2 UA 80870C2
Authority
UA
Ukraine
Prior art keywords
thymosin alpha
prevention
treatment
aspergillus
aspergillus infections
Prior art date
Application number
UAA200509921A
Other languages
English (en)
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of UA80870C2 publication Critical patent/UA80870C2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200509921A 2003-03-28 2004-03-29 Method for treatment or prevention of aspergillus infections with thymosin alpha 1 UA80870C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45791103P 2003-03-28 2003-03-28
PCT/US2004/009550 WO2004087067A2 (en) 2003-03-28 2004-03-29 Treatment of aspergillus infections with thymosin alpha 1

Publications (1)

Publication Number Publication Date
UA80870C2 true UA80870C2 (en) 2007-11-12

Family

ID=42828702

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200509921A UA80870C2 (en) 2003-03-28 2004-03-29 Method for treatment or prevention of aspergillus infections with thymosin alpha 1

Country Status (17)

Country Link
US (2) US8207294B2 (ru)
EP (1) EP1613340B1 (ru)
JP (1) JP4629033B2 (ru)
KR (1) KR101089145B1 (ru)
AT (1) ATE467422T1 (ru)
AU (1) AU2004226403B2 (ru)
BR (1) BRPI0408892A (ru)
CA (1) CA2520400C (ru)
DK (1) DK1613340T3 (ru)
EA (1) EA008037B1 (ru)
IL (1) IL171118A (ru)
MX (1) MXPA05010391A (ru)
NO (1) NO329997B1 (ru)
NZ (1) NZ542900A (ru)
PL (1) PL1613340T3 (ru)
UA (1) UA80870C2 (ru)
WO (1) WO2004087067A2 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2801808C1 (ru) * 2022-03-14 2023-08-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ хирургического лечения крупных подплеврально расположенных туберкулезных каверн легких, не дренируемых бронхом

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207294B2 (en) 2003-03-28 2012-06-26 Sciclone Pharmaceuticals, Inc. Treatment of Aspergillus infections with alpha thymosin peptides
NZ555571A (en) * 2004-12-06 2009-02-28 Sciclone Pharmaceuticals Inc Alpha thymosin peptides as cancer vaccine adjuvants
ES2553267T3 (es) * 2006-05-19 2015-12-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Timosina alfa 1 para uso en el tratamiento de la enfermedad de injerto contra huésped
ITRM20060583A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
CN103458681A (zh) * 2011-02-09 2013-12-18 赛生制药有限公司 用于预防感染、降低感染的严重性、及治疗感染的胸腺素α肽
BR112017016205A2 (pt) * 2015-02-09 2018-03-27 Romani Luigina thymosin alpha 1 para uso no tratamento de fibrose cística
ITUB20153714A1 (it) * 2015-09-18 2017-03-18 Luigina Romani Timosina alfa 1 per l?uso nel trattamento della fibrosi cistica.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
US4079127A (en) 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4116951A (en) 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
US4612365A (en) 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4374197A (en) 1980-10-30 1983-02-15 Hoffmann-La Rocche Inc. Process for thymosin α1
TW224053B (ru) 1991-09-13 1994-05-21 Paul B Chretien
CN1058500C (zh) 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
CN1072961C (zh) 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
TW252045B (ru) * 1993-10-07 1995-07-21 Allan L Goldstein
RU2107692C1 (ru) * 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US5888980A (en) 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5632983A (en) 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
AU6164898A (en) * 1997-02-18 1998-09-08 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha 1 for the manufacture of a medicament for promoting stem cell development
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
US8207294B2 (en) 2003-03-28 2012-06-26 Sciclone Pharmaceuticals, Inc. Treatment of Aspergillus infections with alpha thymosin peptides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2801808C1 (ru) * 2022-03-14 2023-08-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ хирургического лечения крупных подплеврально расположенных туберкулезных каверн легких, не дренируемых бронхом

Also Published As

Publication number Publication date
US20070129292A1 (en) 2007-06-07
EA008037B1 (ru) 2007-02-27
EP1613340A2 (en) 2006-01-11
MXPA05010391A (es) 2005-11-04
BRPI0408892A (pt) 2006-04-11
US8207294B2 (en) 2012-06-26
JP4629033B2 (ja) 2011-02-09
NZ542900A (en) 2007-06-29
KR101089145B1 (ko) 2011-12-02
CA2520400C (en) 2013-02-19
PL1613340T3 (pl) 2010-10-29
EP1613340A4 (en) 2009-07-01
EA200501414A1 (ru) 2006-04-28
JP2006521406A (ja) 2006-09-21
ATE467422T1 (de) 2010-05-15
EP1613340B1 (en) 2010-05-12
NO329997B1 (no) 2011-02-07
NO20054912D0 (no) 2005-10-24
WO2004087067A2 (en) 2004-10-14
AU2004226403A1 (en) 2004-10-14
WO2004087067A3 (en) 2004-12-29
IL171118A (en) 2011-10-31
DK1613340T3 (da) 2010-08-30
US8389680B2 (en) 2013-03-05
AU2004226403B2 (en) 2008-12-04
KR20050114264A (ko) 2005-12-05
NO20054912L (no) 2005-12-20
US20120295840A1 (en) 2012-11-22
CA2520400A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
HK1094320A1 (en) Antiseptic compositions, methods and systems
EP2308963A3 (en) System for processing lipoaspirate cells
ATE319312T1 (de) Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
HK1102085A1 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
EP2011489A3 (en) Method to inhibit ischemia and reperfusion injury
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MXPA01010982A (es) Uso de phyllanthus para la estimulacion dirigida al objetivo del sistema inmune.
NO20054912D0 (no) Behandling av aspergillus infeksjoner med tymosin alfa 1
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
EA201100413A1 (ru) Способ лечения бактериальной инфекции
EP2332555A3 (en) Methods of using regenerative cells to promote wound healing
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
WO2005060960A3 (en) Use of histamine to treat bone disease
WO2005062739A3 (en) S-allylmercaptocysteine prodrugs and methods of treatment
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ZA200402232B (en) Method for treating hepatitis C virus infection in treatment failure patients.
PL374524A1 (en) Composition based on triethyl citrate for the treatment of bacterial infections of the skin
WO2004009029A3 (en) Compositions and methods for treating and preventing infection
EP1620061A4 (en) ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRES
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS
WO2005000239A3 (en) Lyase treatment for p. carinii
AU2003300023A8 (en) Method for treating an environment that may be or is contaminated with an undesirable bacteria, virus and/or spore
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
CY1110218T1 (el) Αγωγη των λοιμωξεων απο ασπεργιλλο με θυμοσινη αλφα 1